C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 57/100How is this calculated?

TLRY’s Earnings Test Is Cash, Not Adjusted EBITDA

Tilray’s fiscal 2027 outlook raises the central cannabis-equity question: can diversified revenue and EBITDA growth finally convert into durable free cash flow?

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.